alyssawinkler.bsky.social
@alyssawinkler.bsky.social
Chemical and Computational Biologist
Lens on Cancer Epigenetics | UMich 〽️
Let's make "undruggable" obsolete
Reposted
March 10, 2025 at 7:12 AM
Yesterday I attended the @standupforscience.bsky.social rally in DC. I appreciate the organizers and all the inspiring speakers; I feel some hope for U.S. the first time in a long time. Looking for how I can find this energy and get involved in Michigan!
March 9, 2025 at 3:12 AM
Reposted
Use this form to tell us how the new US administration is affecting your research, or suggest future coverage

https://go.nature.com/4aYn9Me
Are the Trump team’s actions affecting your research? How to contact Nature
Use this form to share information with Nature’s news team, or to make suggestions for future coverage.
go.nature.com
February 15, 2025 at 12:26 PM
Reposted
NIH doesn’t just support infectious disease research—it drives breakthroughs in cancer, childhood diseases, heart disease, diabetes & more.

Thanks to NIH, we have:
💉 Cancer immunotherapy
❤️ Cholesterol-lowering statins
🩸 Insulin for diabetes

Investing in NIH = investing in life-saving discoveries.
February 8, 2025 at 3:07 PM
govdiff.com
Have to share this tool for transparency as shared online information changes.
GovDiff — Compare Government Websites Before and After Trump
govdiff.com
February 8, 2025 at 4:57 PM
Strong agree. Peer review needs to retain some credibility here.
bmj.com The BMJ @bmj.com · Feb 4
The US was considered a world leader in public health and research. With one repressive stroke that reputation risks being broken, argue @jocalynclark.bsky.social and @kamranabbasi.bsky.social www.bmj.com/content/388/...
February 6, 2025 at 11:49 PM
April 22nd 2025?
February 5, 2025 at 11:22 PM
Reposted
Roughly 6,000 readers answered our poll, with many declaring that Bluesky was nicer, kinder and less antagonistic to science than X

https://go.nature.com/42tH8Ai
Bluesky’s science takeover: 70% of Nature poll respondents use platform
Roughly 6,000 readers answered our poll, with many declaring that Bluesky was nicer, kinder and less antagonistic to science than X.
go.nature.com
January 24, 2025 at 11:52 AM
Excellent feature by Andy Extance in RSC on the history, function, and future of targeted protein degradation #TPD
January 14, 2025 at 3:16 PM
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes www.nytimes.com/2025/01/07/h...
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.
www.nytimes.com
January 8, 2025 at 12:37 PM
Check out this paper and the models provided, will have seriously exciting applications for both preclinical and clinical researchers. Also gives a nice example about just how ML will be used to guide precision cancer diagnostics and therapy!
January 7, 2025 at 4:17 PM
Check out the latest paper from the Cierpicki and Grembecka labs detailing the development of novel PRC1 inhibitors, which bind to the RING1B/BMI1 catalytic core to block H2AK119ub deposition. Excited to continue this story with characterization in AML and other leukemia models!
Development of PRC1 Inhibitors Employing Fragment-Based Approach and NMR-Guided Optimization
Polycomb Repressive Complex 1 (PRC1) is associated with transcriptional silencing, and its dysregulation plays an important role in various cancers. Well-characterized PRC1 inhibitors can facilitate t...
pubs.acs.org
January 3, 2025 at 5:42 PM
Reposted
While the risk of human-to-human transmission is still low, the pervasive reservoirs and appearance of new, concerning mutations or those identified as a threat science.org/doi/10.1126/...
demand a very high level of vigilance and preparedness
A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors
In 2024, several human infections with highly pathogenic clade 2.3.4.4b bovine influenza H5N1 viruses in the United States raised concerns about their capability for bovine-to-human or even human-to-h...
science.org
December 31, 2024 at 11:44 PM
Reposted
There have been 5 articles in @nytimes.com recently on University of Michigan DEI quoting a few unhappy people.

In just 6 days the DEI office collected 1,000 testimonials from individuals impacted positively.

It should be required reading.

Too bad that perspective won’t be published.
December 19, 2024 at 2:16 AM